Abstract
Ophthalmic plaque radiation therapy continues to offer patients an eye- and vision-sparing alternative to enucleation. Pioneers of this technique first used high-energy plaques that incorporated cobalt 60 (60Co).1 Since that time ruthenium 106 (106Ru) largely replaced Co60 in Europe, as did low-energy iodine 125 (125I) in North America.1–5 Plaque radiotherapy with these new radionuclides (isotopes) delivers less unwanted radiation to the patient, the surgeon, and health care personnel.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
